Medtronic Graft Bone Infustion

The MEDTRONIC INFUSE BONE GRAFT contains a synthetic protein called recombinant human bone morphogenetic protein (rhBMP-2) that promotes bone growth. It has been approved for spinal applications, tibia repairs, and dental procedures.

However, it has been linked to life-threatening complications including:

  • swelling of the airways
    • difficulty swallowing
    • difficulty breathing
    • difficulty speaking
  • uncontrolled bone growth at or near the surgery site
  • infections
  • cancer
    • including thryoid, stomach, breast, skin melanoma, ovarion, laryngeal, pancreatic, lung, lymphoma
  • sterility
  • bone and nerve injuries
  • urinary problems.

January 22, 2015 the FDA issued a safety alert that recombinant proteins or synthetic bone graft substitutes should not be used in minors under the age of 18.

Medtronic lawsuits allege the manufacturer illegally promoted the Medtronic bone product for off-label use in certain surgeries. If you or a loved one have questions about the MEDTRONIC INFUSE BONE GRAFT, call your local products liability attorneys, THE RUTH LAW TEAM, at 1-888-783-8378.